4/A//SEC Filing
TENDLER DAVID 4/A
Accession 0001210437-04-000003
CIK 0000722104other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 1:52 PM ET
Size
6.4 KB
Accession
0001210437-04-000003
Insider Transaction Report
Form 4/AAmended
TENDLER DAVID
Director
Transactions
- Award
Common stock, $.01 par value per share
2003-12-31$4.61/sh+542$2,499→ 14,927 total - Award
Options to purchase common stock, $.01 par value per share
2003-12-31$4.61/sh+5,000$23,050→ 97,500 totalExercise: $4.61From: 2004-12-31Exp: 2013-12-31→ Common stock, $.01 par value per share (5,000 underlying)
Footnotes (3)
- [F1]These shares were granted pursuant to the Company's Stock Compensation Plan for Outside Directors, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $2,500, until he is no longer an Outside Director. On December 31, 2003, the fair market value of the Common Stock, based on the closing price, was $4.61.
- [F2]These options will become fully vested and immediately exercisable on 12/31/2004.
- [F3]This stock grant was originally reported in Table 1 Column 4 with the incorrect transaction code. The stock grant was originally reported in Column 4 as "D" for securities disposed of instead of "A" for securities acquired.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001210437
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 1:52 PM ET
- Size
- 6.4 KB